Pure Global
NCT06385639

Efficacy and Safety of Probiotic Products for Digestive Health

A Double-blind, Randomized Clinical Study, Compared With Placebo to Assess the Efficacy and Safety of a Probiotic Product Containing Four Probiotic Strains to Support Digestive Environment and Homeostasis of Gut Microbiota
Wecare Probiotics Co., Ltd.·ClinicalTrials.gov·dietary supplementRecruiting
View on ClinicalTrials.gov →
Study focus
Disease/Condition
Healthy Adult
Drug/Device/Intervention
Probiotic
Study type
Interventional
Intervention type
dietary supplement
Sponsor & location
Primary sponsor
Wecare Probiotics Co., Ltd.
Location
Jakarta, Indonesia
Timeline & enrollment
Phase
N/A
Start date
Apr 25, 2024
End date
Jun 25, 2024
Enrollment
60 participants
Primary outcome

Intestinal health

Summary

The objective of this study is to evaluate the efficacy and safety of the probiotic product
 as an everyday gut health product in supporting digestive environment and homeostasis of gut
 microbiota.

ICD-10 classifications
Healthy person accompanying sick personObesity, unspecifiedLifestyle-related conditionAdult-onset Still diseaseObesity
Data source
Registry
ClinicalTrials.gov
Trial ID
NCT06385639
Type
Non-Device Trial
About this record

Access comprehensive clinical trial information for NCT06385639 through Pure Global AI's free database. This phase not specified trial is sponsored by Wecare Probiotics Co., Ltd. and is currently Recruiting. The study focuses on Healthy Adult. Target enrollment is 60 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.